Open AccessDiabetes mellitus in the young: Gliptins or sulfonylurea after metformin?
Author(s) -
J Muthukrishnan,
Saurabh Dawra,
Vishal Marwaha,
JS Bishnoi,
CS Narayanan
Publication year - 2012
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.104136
Subject(s) - glimepiride , sitagliptin , medicine , metformin , glycemic , diabetes mellitus , endocrinology , sulfonylurea , hypoglycemia , vildagliptin , insulin , gastroenterology
Diagnosis and initial management of diabetes mellitus (DM) in the young are clinical dilemma. Gliptins may be a safer and more effective option than sulfonylureas. Few Indian studies have addressed this issue of clinical relevance.